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Metabolism of high  density  lipoprotein (HDL) cho- 
lesteryl ester (CE) by cultured rat adrenal cells was 
studied. Addition of ['HICE-HDL to cells pretreated 
with  adrenocorticotrophin  in  lipoprotein poor media 
resulted  in a time- and concentration-dependent accu- 
mulation of ['H]cholesteryl ester and production of  ['HI 
cholesterol and ['H]corticosterone. HDL-CE metabo- 
lism could be  described as the sum of a high  affinity 
([HDL-chole~terol]~~ = 16 rg/ml)  and low affinity 
([HDL-ch~lesterol]~~ > 70 pg/ml) process. ['HICho- 
lesterol  was found  both  intracellularly  and  in  the me- 
dia. Accumulation of ['H]cholesteryl ester could not be 
attributed  to  uptake  and  re-esterification of unesteri- 
fied  cholesterol  since  addition of Sandoz 58-035, an 
inhibitor of acyl coenzyme A:cholesterol acyltransfer- 
ase, did not prevent ester accumulation. Moreover, 
addition of chloroquine  did not inhibit  cholesteryl ester 
hydrolysis  indicating that hydrolysis was not lysoso- 
mally mediated. 
Aminoglutethimide prevented  conversion of  ['HICE- 
HDL to  steroid  hormones  but  did not inhibit ['Hlcho- 
lesteryl ester uptake. Cellular accumulation of ['HI 
cholesteryl ester exceeded accumulation of '261-apo- 
proteins  5-fold at 1 h and 35-fold at 24 h indicating 
selective uptake of cholesteryl ester moiety. We con- 
clude that  rat  adrenal cells possess a mechanism for 
selective uptake of  HDL cholesteryl esters which  pro- 
vides substrate  for steroidogenesis. These  results con- 
stitute  the  first  direct  demonstration  that cholesteryl 
esters in HDL can be used as steroidogenic substrate 
by the  rat  adrenal  cortex. 
Cholesterol is an obligate intermediate in the synthesis of 
steroid hormones. Uptake of extracellular lipoprotein choles- 
terol is an important source of substrate  in most steroidogenic 
tissues (1). It is now apparent that at least three distinct 
mechanisms exist for cellular uptake of lipoprotein choles- 
terol. These include receptor-mediated endocytosis (2 ) ,  
aqueous diffusion (3, 4),  and  a poorly understood nonendo- 
cytotic process for selective uptake of cholesteryl esters (5- 
8). Specific receptors which recognize apoB (9), apoE (lo), or 
modified apoB (11, 12) mediate endocytosis of intact lipopro- 
tein particles. Lipoproteins lacking these apoprotein deter- 
minants do not deliver cholesteryl esters by receptor-mediated 
endocytosis. 
Net cellular uptake of unesterified cholesterol can occur by 
aqueous diffusion or by a process, perhaps involving direct 
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lipoprotein cell contact  but no more energetically favorable 
than aqueous diffusion (3, 13). Because of the low aqueous 
solubility of cholesteryl esters, cellular uptake of cholesteryl 
esters does not occur by aqueous diffusion (3). 
A third process for net cholesterol movement is exemplified 
by rat adrenal  uptake of HDL' cholesterol (5-8, 14).  In the 
rat adrenal cortex HDL is the preferred lipoprotein source of 
steroidogenic substrate cholesterol (1). Uptake of HDL cho- 
lesteryl esters  cannot be attributed  to receptor-mediated en- 
docytosis or to aqueous diffusion (7,14). Lipoprotein particles 
lacking apoproteins recognized  by endocytosed receptors, such 
as  human HDL3, are nonetheless able to enhance rat adrenal 
steroid production by  delivery of substrate cholesterol. Recent 
studies from our laboratory suggest that unesterified choles- 
terol accounts for only a  portion of the steroidogenic substrate 
cholesterol taken  up by this process, since esterification of 
HDL cholesterol only partially diminishes HDL-dependent 
steroid hormone synthesis  (14).  In  addition,  reports by Pitt- 
man, Glass and  their colleagues (6, 7) as well as Leitersdorf 
et al. (8) using HDL labeled with cholesteryl ethers,  a  non- 
degradable marker for cholesteryl esters, indicate that adre- 
nal, hepatic, and  other tissues of both  rodents  and  humans 
can selectively accumulate cholesteryl esters considerably in 
excess of HDL apoprotein. Nestler et al. (15) using HDL 
doubly labeled in the cholesterol and cholesteryl ester moieties 
have shown that  rat ovarian granulosa cells utilize cholesteryl 
esters for synthesis of progesterone. Verschoor-Klootwyk et 
al. (16) have also presented evidence for cholesteryl ester 
uptake from HDL although their studies did not preclude 
uptake mediated by apoE. 
The inverse relationship between HDL cholesterol (17, 18) 
or its major apoprotein A-I (19) and risk of coronary heart 
disease has stimulated study of cellular HDL metabolism. 
Rodent steroidogenic tissues provide a novel and useful sys- 
tem for the study of cellular HDL metabolism. In these 
tissues, HDL metabolism is hormonally regulated and pro- 
duces a physiologic response, increased steroidogenesis (5, 
20). Current evidence suggests that one way in  which HDL 
may protect  against coronary heart disease is through "reverse 
cholesterol transport," the removal of cholesterol from pe- 
ripheral tissues  and subsequent delivery to  the liver for excre- 
tion (21, 22). A thorough understanding of HDL metabolism 
at  the cellular level is essential to complete understanding of 
the anti-atherogenic  actions of HDL. Much has been learned 
about HDL metabolism by steroidogenic and other tissues 
through the use of nonhydrolyzable cholesteryl ethers (6-8). 
Since cholesteryl ethers cannot be hydrolyzed, they do not 
provide a suitable probe for  following further the metabolism 
'The  abbreviations used are: HDL, high density  lipoprotein; 
ACTH,  adrenocorticotrophin; AG, aminoglutethimide; 1.125B, serum 
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of accumulated cholesteryl esters. Moreover, because the 
ethers  cannot be metabolized they may have unappreciated 
pharmacologic effects intracellularly, although they  are me- 
tabolized normally intravascularly (6,8). We have undertaken 
the current studies to directly examine the metabolism of 
HDL cholesteryl esters in rat adrenocortical cells. While 
previous studies have clearly documented that adrenal tissue 
can selectively accumulate cholesteryl ethers  and  esters (6- 
8), only indirect evidence suggests that cholesteryl esters  in 
HDL may be utilized by the adrenal for steroid substrate. 
Since no definitive proof has yet been presented, the first 
objective of our  studies was to determine if cholesteryl esters 
in HDL could be utilized for corticosterone production. As a 
basis for determining the molecular mechanisms responsible 
for cholesteryl ester uptake, we have further characterized the 
uptake process. Finally, since only unesterified cholesterol 
can undergo side chain cleavage, the committed step in ste- 
roidogenesis, we have examined cell-mediated hydrolysis of 
HDL cholesteryl esters. 
EXPERIMENTAL PROCEDURES 
Lipoprotein Preparation, Labeling, and Characterization-To ex- 
amine the metabolism of HDL cholesteryl esters independently of 
the apoB,E receptor pathway, we required HDL which  was (a) free 
of apoE (5) contained radiolabeled cholesteryl esters, ( c )  contained 
no radiolabeled unesterified cholesterol, and ( d )  retained native ste- 
roidogenic activity. Human HDL3  was chosen since it is essentially 
free of apoE. In previous studies employing purified HDL, (14) not 
subjected to heparin-Sepharose chromatography, apoE was undetect- 
able by sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
and present in less than 0.3% of total protein by radioimmunoassay. 
Moreover, our previous studies have shown that human HDLa does 
not enhance rat adrenal steroidogenesis through the low density 
lipoprotein pathway (5, 14, 24). In the current studies we have, in 
some cases, employed human HDL3 further freed of apoE by passage 
over a heparin-Sepharose affinity column (25). 
Human serum HDL was labeled with [3H]cholesteryl-oleate by a 
modification of the method of Thomas and Rude1 (26). To enhance 
the efficacy of labeling and prevent modification of HDL, we have 
employed serum of d > 1.125 g/ml (hereafter  termed 1.125B) rather 
than whole serum. Plasma was collected in EDTA (1 mg/ml) from 
normal human volunteers and centrifuged at d = 1.125 g/ml for 18 h, 
at 8 "C using a Beckman Ti-60 fixed angle rotor. The upper half of 
the screw top tube was aspirated and discarded. The lower half, 
(1.125B),  was dialyzed against at least four changes of 50 volumes of 
0.15 M NaCl containing EDTA (0.01%). Our previous studies (15) 
have shown that incubating 1.125B for 18 h at 37 'C causes loss of 
steroidogenic activity as a result of cholesterol esterification. To 
ensure retention of native HDL properties, we therefore inactivated 
lecithin cholesterol acyltransforase (27) by incubating 1.125B under 
nitrogen at 56 "C for 30  min prior to labeling or further purification. 
Subsequently, inactivated 1.125B was labeled by incubation under 
nitrogen at 37 "C for 18-24 h  in screw top glass tubes which had [3H] 
cholesteryl-oleate dried onto 100-200  mg  of Celite 545 (Supelco Inc., 
Bellefonte, PA). Incubations were performed with 1.125B rather than 
purified HDL in order to provide a source of cholesteryl ester ex- 
change protein. Usually 5-7 ml of 1.125B  was incubated with 100- 
200 pCi of [3H]cholesteryl-oleate which had been purified by TLC. 
At the end of the labeling incubation, celite was  removed by centrif- 
ugation and millipore (.02 micron) filtration. In preliminary experi- 
ments, the degree of labeling observed with purified HDL was less 
than 10% of that seen with 1,125B. Typically, 40 to 60% of the label 
was incorporated and specific activities ranged from 12800 to 75000 
dpm/pg cholesterol At the completion of the labeling incubation 
greater than 99% of the incorporated label co-migrated with choles- 
teryl oleate on TLC. 
To determine if labeling altered the lipoprotein, fluorogenic steroid 
production by ACTH/LPP-pretreated rat adrenal cells incubated 24 
h with [3H]cholesteryl oleate labeled or unlabeled 1.125B, added at 
equal total cholesterol concentration, was compared. In six compari- 
sons of five different preparations, the mean steroid production for 
labeled materials (0.872 k 0.338 pg/well/l8 h) was identical to  that 
for unlabeled 1.125B  (0.887 f 0.437 pg/well/l8 h). Paired  Student's 
t test showed that the difference between labeled and unlabeled 
materials was not different from zero (n  = 6, p = 0.837) indicating 
that  the labeling procedure had preserved native HDL activity. All 
labeled HDL, and 1.125B preparations were tested and used only if 
normal steroidogenic activity was retained. Our previous studies (14) 
have shown that in the presence of LPP-fetal calf serum, 1.125B and 
purified HDL3 support steroidogenesis equally well. We have used 
1.125B interchangeably with HDL3. In some cases, HDL3  was further 
purified by sequential ultracentrifugation as previously described (14) 
and freed of apoE by column chromatography on heparin-Sepharose 
(25). Lipoprotein purity was checked by sodium dodecyl sulfate- 
polyacrylamide gel electrophoresis (28). No apoE was detected either 
before or  after column purification. Purified HDLJ and human HDL 
were iodinated using a modification of the iodine monochloride pro- 
cedure described by Bilheimer et al. (29) as previously described (30). 
Lipoprotein poor human or fetal calf serum were prepared by cen- 
trifugation at d = 1.215 g/ml for 48 h, as previously described (14). 
Unlabeled human HDL3 (1.125 < d < 1.215 g/ml) and low density 
lipoprotein (1.019 < d < 1.055 g/ml) were purified by sequential 
density ultracentrifugation as previously described (14). 
Cell Preparation and Culture-Suspensions of adrenocortical cells 
were prepared from glands excised from 21-42-day-old female 
Sprague-Dawley rats by collagenase-DNase digestion using a modi- 
fication of the method of O'Hare and Neville (31) as previously 
described (14). Cells  were initially plated on multiwell dishes (Falcon 
3847) in F-l2/Dulbecco's modified Eagle's medium (1:l) supple- 
mented with 10% fetal calf serum (Hyclone) plus penicillin (100 
units/ml) and streptomycin (100 pg/ml) and gentamycin (100 pg/ml) 
plus 3% bovine brain growth supplement (standard media). The 
conditions of culture were similar to those described by McAllister 
and Hornsby (32). The bovine brain growth supplement was prepared 
by a modification of the method of Gospodarowicz et al. (33) omitting 
the final column purification. In some cases, 2% (v/v) Ultroser-G 
(IBF Biotechnics, Savage, MD) was substituted for bovine brain 
growth supplement. In preliminary experiments, addition of neither 
the bovine growth supplement nor Ultroser had any acute effect on 
steroidogenesis or metabolism of [3H]cholesteryl-ester in HDL  (data 
not shown). 
Except where noted, we have used confluent monolayer cultures 
which  were pretreated for 48 h with ACTH (lo" M) in lipoprotein 
poor media. This approach was chosen to enhance the utilization of 
extracellular cholesterol substrate, based on our earlier studies (5). 
Assays-Cholesterol and cholesteryl ester were measured enzymat- 
ically using reagents supplied in kit form by Boehringer Mannheim 
(No. 124087, West Germany). Steroid hormone production was meas- 
ured fluorometrically using a modification of the method of Kowal 
and Fiedler (34), as previously described (15). Corticosterone was 
used as the standard, and the results are expressed in terms of 
corticosterone equivalents, the amount of corticosterone required to 
produce a fluorescent signal equal to the unknown. Protein was 
measured according to Lowry et al. (35) using bovine serum albumin 
as a  standard. Corticosterone was isolated from methylene chloride 
extracts of media by TLC on aluminum-backed silica gel plates (Silica 
Gel-60, MCB Reagents, Gibbstown, NJ) developed with toluene/ 
acetone (8020). Lipids and steroids, extracted from media with chlo- 
roform/methanol according to Bligh and Dyer (36), were similarly 
isolated by TLC on silica gel plates. The isolated products were cut 
from the sheets and added directly to Safety-Solve (Research Prod- 
ucts International, Mount Prospect, IL) scintillation mixture prior to 
counting using a Rackbeta liquid scintillation counter (LKB  Instru- 
ments, Gaithersburg, MD). Cell cholesterol was extracted with iso- 
propyl alcohol as described by Johnson et al. (13). Degradation of 
apoproteins in HDL was determined by measurement of total media 
lZ5I which did not precipitate when  made 10% in trichloroacetic acid 
for 60 min at 4 'C (37). Statistical analyses were performed using 
Epistat, public domain software for IBM microcomputers.* 
Materials-Heparin-Sepharose was obtained from Pharmacia 
LKB Biotechnology Inc. lZ5I and [3H](1,2)-cholesteryI-oleate were 
purchased from Du Pont-New England Nuclear. [3HlCholesteryl- 
oleate was chromatographed on TLC plates prior to use. 
RESULTS 
To determine if cholesteryl esters in HDL could serve as 
steroidogenic substrate, HDL3 (1.125 < d < 1.21 g/ml) labeled 
with [3H]cholesteryl-oleate was incubated with primary con- 
' T. L. Gustafson, Round Rock, TX 78664. 
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fluent monolayer cultures of rat adrenocortical cells pre- 
treated with ACTH in lipoprotein poor media for 48 h. The 
following  two types of labeled HDL  preparations were used 
(i) partially purified HDL3 consisting of plasma of d > 1.125 
g/ml (3H-CE-1.125B) and (ii) fully purified HDL3 prepared 
from 1.125B by centrifugation and freed of apoE by heparin- 
Sepharose chromatography (apoE-free 3H-CE-HDL). In sep- 
arate experiments employing eight different cell preparations 
and five different labeled HDL  preparations, with concentra- 
tions of HDL cholesterol ranging from 4.8 to 100 pg/ml, from 
1.5 to 17.5% of the added counts were converted to steroid 
products  (Table  I). Similar results were observed with par- 
tially purified 3H-CE-HDL (3H-CE-1.125B) (Table I, experi- 
ments 1 and 2) and  ap~E-free-~H-cE-HDL~ (Table  I, experi- 
ments 3-8). Within single experiments, the percent of added 
counts converted to steroid products decreased as  the concen- 
tration of HDL increased. 
Control studies were performed to confirm that counts 
recovered from the media were products of cell-mediated 
steroidogenesis. Production of fluorogenic steroids (panel A )  
and radiolabeled steroid products (panel B )  for a  represent- 
ative control experiment are shown in Fig. 1. In  the absence 
of added lipoprotein (column 1 )  or in the absence of cells 
(column 3) no radiolabeled steroid products were formed. In 
the absence of added lipoprotein (column I), cells produced 
1.50 f 0.01 pg  of corticosterone equivalents/well. Addition of 
3H-CE-HDL (column 2 )  increased sterol production 3.3 times 
and resulted in conversion of 3.4% of the added counts to 
steroid products. Addition of aminoglutethimide (AG) (col- 
umn 4 )  or cyanide/fluoride (column 5 )  inhibited both fluoro- 
genic and radiolabeled steroid production. Addition of a 5- 
fold excess of unlabeled HDL3 (column 6 )  enhanced fluoro- 
genic steriod production greater than  that produced by addi- 
tion of labeled HDL alone (cf.  column 2 )  but inhibited con- 
version of 3H-CE from HDL to steroid products. 
Incubation of 3H-CE-HDL with cells resulted in cholesteryl 
ester hydrolysis. When introduced into the media, greater 
than 99% of the HDL radioactivity comigrated on TLC with 
cholesteryl esters (Fig. 2). Only background counts were re- 
covered from TLC  plates at  the position of unesterified cho- 
lesterol and corticosterone. The percent of counts recovered 
from the media was unesterified cholesterol following incu- 
bation for 24 h in the absence of cells increased from 0.34 & 
0.03% to 1.34 f 0.05% (p < 0.001) while the percent of counts 
recovered as cholesteryl ester decreased accordingly (99.5 f 
0.05% to 98.4 f 0.07%, p < 0.001). No change in the percent 
of added counts recovered as steroid products occurred (0.210 
f 0.01% uersus 0.24 f 0.03%, p = .29). In  three similar cell- 
free incubations, from 0.94 to 1.3% of the added counts were 
recovered as unesterified cholesterol. In  contrast, in the pres- 
ence of cells, counts recovered as unesterified cholesterol 
increased to 2.89 f 0.08% (p < 0.001 cf. unincubated sample) 
and counts recovered as cholesteryl ester decreased to 92.5 & 
0.53% (p < 0.001 cf. unincubated sample) of counts recovered 
from the media. Counts recovered as steroid product increased 
to 4.65 zk 0.47%, p < 0.001, cf. unincubated sample) of added 
counts. Thus,  the percent of added 3H-CE converted to steroid 
products  is severalfold greater than  the percent of unesterified 
counts recovered  from unincubated material or  material  in- 
cubated in  the absence of cells. 
Following incubation of 3H-CE-HDL with cells, 3H-unes- 
terified cholesterol was found both cell associated and in the 
media as well. Total cell-mediated hydrolysis was considered 
to be the sum of media and cell unesterified cholesterol less 
the amount of unesterified cholesterol generated in the  ab- 
sence of cells. To determine if hydrolysis of HDL cholesteryl 
esters  is lysosomally mediated, we compared the amount of 
3H-CE from HDL hydrolyzed by cells incubated in  the pres- 
ence and absence of chloroquine. The amount of 3H-CE from 
HDL hydrolyzed  by the cells in the presence of chloroquine 
was the same or even greater than in its absence (Fig. 3). 
Although, no inhibition of 3H-CE hydrolysis was observed, 
chloroquine (100 p ~ )  did inhibit fluorogenic steroid produc- 
tion by 42.5%, an observation previously noted by others (38) 
TABLE I 
Synthesis of steroid hormones from HDL cholesteryl esters 
All incubations were conducted for 18 h in 15-mm miniwell cluster dishes in a total media  volume  of 0.4 ml. 
Cells were pretreated for 24 or 48 h with ACTH M) in lipoprotein poor media. Steroid production in the 
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Difference in total fluorogenic steroid production in  the presence and absence of HDL. 
* Total steroid hormone production estimated to be twice the amount determined by fluorescence (29). 
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1 2 3 4 5 6  
FIG. 1. Effects of inhibiting steroidogenesis on conversion 
of 3H-CE from HDL to steroid hormones. Primary confluent 
monolayer cultures of rat adrenocortical cells, pretreated for 48 h 
with ACTH (lo" M) in  lipoprotein  poor  media,  were incubated for 
18 h with ACTH M) (all columns) and H3-CE-1.125B (35 pg of 
cholesterol/ml) (columns 2-6) and the following additions: column 4, 
aminoglutethimide  (800 p ~ ) ;  column 5, cyanide  (10 mM) plus  fluoride 
(10 mM); or column 6, unlabeled HDL (180 pg of cholesterol/ml). 
Column 3 is identical with 2 except cell free. At the end of the 
incubation, the media was divided and fluorogenic  steroid  production 
was  measured on 1 aliquot (A) and  3H-steroids on the other (B) .  Cort, 
corticosterone  equivalents. 
1 0 0  
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FIG. 2. Cell-mediated hydrolysis of HDL cholesteryl esters. 
3H-CE-1.125B  (17.8 pg of total cholesterol/ml) was incubated for  24 
h at 37 "C in 5% CO? in lipoprotein poor media, with confluent 
monolayer cultures of rat adrenocortical cells in 24-multiwell  dishes. 
Control  incubations were performed  under  identical  conditions in the 
absence of cells. The resultant products  were extracted,  separated by 
TLC,  and compared  with  similarly extracted  and  chromatographed 
unincubated  3H-CE-1.125B  held  under  nitrogen at 4 "C. 
and specific receptor-mediated degradation of human lz5I- 
LDL by 81% (triplicate  determination from triplicate exper- 
iments, data not  shown). 
To determine if cell-accumulated  [3H]cholesteryl esters 
arose from re-esterification of hydrolyzed HDL cholesteryl 
esters, we measured cell accumulation of 3H-CE  in  the  pres- 
ence of Sandoz 58-035, an  inhibitor of acyl-coenzyme 
A.cholestero1-acyltransferase (39). Preliminary studies were 
performed to  determine  the  concentration of Sandoz 58-035 
required to inhibit cholesterol esterification in rat adrenal 
cells. When cells were incubated  with [3H]cholesterol,  added 
in ethanol,  in  the presence of increasing doses of Sandoz 58- 
035 and AG, to  prevent conversion of accumulated  t3H]cho- 
lesterol to  steroid  products,  dose-dependent  inhibition of cho- 
lesterol esterification was observed  (Fig.  4). Fifty % inhibition 
occurred at  a concentration less than 0.1 pg/ml. To determine 
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FIG. 3. Effects of chloroquine on uptake and hydrolysis of 
HDL cholesteryl esters. Primary  confluent monolayer cultures of 
rat adrenocortical  cells  were incubated for  18 h at 37 "C with  3H-CE- 
HDL  (12.5  pg of total cholesterol/ml), AG (800 p ~ ) ,  and ACTH (lo" 
M) in the presence  and  absence of chloroquine (100 p ~ ) .  The cells 
were  thoroughly  washed  and the cell-associated  unesterified  choles- 
terol and cholesteryl esters extracted and separated by TLC.  Data 
shown  are the results of triplicate  determinations of duplicate  exper- 
iments  (mean * S.D.). FC, free  cholesterol; CE, cholesteryl  ester. 
CONCENTRATION 58-035 (Ag/rnl) 
FIG. 4. Dose-dependent inhibition of cholesterol esterifica- 
tion by Sandoz 58-035. Primary monolayer cultures of rat adre- 
nocortical cells were incubated for 18 h with [3H]cholesterol (6.5 X 
105 dpm) added in ethanol (final conc. = 2%) in the presence of 
increasing  doses of Sandoz  58-035  added  in 5 pl of M e 8 0  and AG 
(800 p ~ )  to  prevent  utilization of added  cholesterol  for  steroidogen- 
esis.  Cell  accumulated  dpm  were extracted  with  isopropyl  alcohol  and 
separated by TLC. 
ized cell toxicity, we measured the effects of Sandoz 58-035 
on steroidogenesis. When cells replete  with endogenous cho- 
lesteryl  ester  stores were incubated  with  increasing doses of 
Sandoz 58-035, in  the  absence of AG, no effect on  steroido- 
genesis was observed (Fig. 5A) even at  concentrations of 
Sandoz 58-035  sufficient to  almost completely inhibit choles- 
terol  esterification. 
To determine if utilization of extracellular  cholesterol  re- 
quired passage through  the cholesteryl ester  storage pool, we 
also measured the effects of Sandoz 58-035 on steroidogenesis 
in  the  presence of HDL. Cells were rendered  dependent  on 
extracellular  lipoprotein cholesterol by pretreatment for  48  h 
with  ACTH  in  lipoprotein poor media. Under  these  condi- 
tions, where 80% or more of the substrate cholesterol is 
derived from HDL  (5,  14),  Sandoz 58-035 had  no effect on 
steroid  hormone  production (Fig. 5B)  indicating  that  extra- 
cellular  cholesterol need  not  pass  through  intracellular  storage 
pools  before  being  utilized for steroidogenic substrate. 
Having  shown that  Sandoz 58-035 effectively inhibits  cho- 
lesterol esterification  without  apparent cell toxicity we meas- 
ured the effects of Sandoz 58-035 on cell accumulation of 
radiolabeled  cholesteryl ester derived from HDL3. Cells were 
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CONCENTRATION 58-035(~q/ml) 
FIG. 5. Effects of Sandoz 85-035 on HDL-dependent and 
independent steroidogenesis. A, primary monolayer cultures of 
rat adrenocortical cells which had  not been pretreated were incubated 
for 18 h in fresh complete media (V,, = 0.5 ml) with increasing doses 
of Sandoz 58-035 (added in 0.005  ml of Me2SO). Steroid production 
was measured fluorometrically. B, primary monolayer cultures of rat 
adrenocortical cells, pretreated for 72 h with ACTH/LPP (V,, = 0.5 
ml) were subsequently incubated for 18 h in fresh LPP media supple- 
mented with HDL (50 pg/ml total cholesterol) and increasing doses 
of Sandoz 58-035 (added in 0.005 ml  of  MeZSO). Steroid production 
was measured fluorometrically (mean and S.D. of triplicate measures, 






FIG. 6. Effects of Sandoz 58-035 on cell accumulation of 
3H-cholesteryl ester from HDL. Primary monolayer cultures of 
rat adrenocortical cells were pretreated for 48 h with ACTH/LPP 
and subsequently incubated for 18 h with 3H-CE-1.125B (30 pg/ml 
total cholesterol, specific activity = 42,400 dpm/pg of cholesterol) in 
LPP media with AG (800 p ~ )  and Sandoz 58-035 (1 pg/ml). The cells 
were thoroughly washed and cell-associated unesterified cholesterol 
and cholesteryl esters  extracted and separated by TLC. The mean 
and S.D. of triplicate  determinations from duplicate experiments are 
shown. PC, free cholesterol; CE, cholesteryl ester. 
incubated with 3H-CE-1.125B in the presence of  AG with and 
without Sandoz 58-035. In two separate experiments, addition 
of Sandoz 58-035 produced only a modest decrease in the total 
number of cell-associated counts  and  in  the percent of cell- 
associated counts recovered as cholesteryl esters (Fig. 6). 
Despite effective inhibition of re-esterification, adrenal cells 
accumulate cholesteryl esters when incubated with 3H-CE- 
HDL. 
Having established that cholesteryl esters  in HDL could be 
taken up by rat adrenal cells and used as steroidogenic sub- 
strate we next sought to further characterize the uptake 
process. To determine if cholesteryl ester uptake was second- 
ary to steroid hormone synthesis or perhaps stimulated by 
extracellular steroid products, uptake was compared in  the 
presence and absence of active steroidogenesis. When AG was 
added to ACTH/LPP-pretreated cells and incubated with 3H- 
CE-HDL, cell-associated 3H-sterols increased from 0.457 f 
0.141 to 0.576 f 0.097  pg/well (n = 3, p = 0.042). 
Net cellular metabolism of [3H]cholesteryl ester from HDL 
is comprised of the sum of 3H-steroid production, total cell- 
accumulated 3H-CE  and 3H-unesterified cholesterol plus me- 
dia 3H-unesterified cholesterol, in excess of that found in cell- 
free controls. To determine if addition of  AG stimulated cell 
uptake of HDL cholesteryl esters or simply redirected them 
from steroidogenesis into  alternative pathways, net  HDL-CE 
metabolism was measured in  the presence and absence of AG. 
Addition of  AG prevented conversion of 3H-CE from HDL to 
3H-steroids but did not diminish total cell metabolism (Fig. 
7). In the absence of  AG, addition of excess unlabeled HDL 
with 3H-CE-HDL  inhibited  total cell metabolism of 3H-CE 
(Fig. 7). 
Cellular accumulations of 3H-sterols from HDL was time 
(Figs. 8 and 9) and  concentration (Fig. 10) dependent. When 
3H-CE-1.125B was added to ACTH/LPP-pretreated cells, 
there was an initial rapid increase followed by a prolonged 
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FIG. 7. Effects of aminoglutethimide on uptake and metab- 
olism of HDL cholesteryl esters. Primary confluent monolayer 
cultures of rat adrenocortical cells, pretreated for 48 h with ACTH 
M )  in LPP media, were incubated for 18 h with ACTH (lob7 M), 
3H-CE-HDL (25 pg of total cholesterol/ml) with and without AG (0.8 
mM) or unlabeled HDL (150 pg  of total cholesterol/ml) as indicated. 
Total cell associated 3H-cholesterol (FC + CE) were extracted from 
the cell pellet by isopropyl alcohol. Media 3H-steroids were extracted 
with methylene-chloride and isolated by TLC. The means r+ S.D. of 
triplicate  determinations from a single experiment representative of 
three such experiments are shown. 
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FIG. 8. Time course of cellular accumulation of HDL cho- 
lesteryl  esters. Confluent monolayer cultures of rat adrenocortical 
cells, pretreated for 48 h with ACTH M) in LPP media, were 
incubated for the indicated times with 3H-CE-HDL  (25 pg of total 
cholesterol/ml), ACTH M) ,  and AG (0.8 mM). The cells were 
thoroughly washed and cell associated [3H]cholesterol extracted with 
isopropyl alcohol and counted. The mean and S.D. of triplicate 
determinations from a single experiment representative of three such 
experiments is shown. 
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FIG. 9. Comparison of the accumulation of [3H]cholesterol 
and '"1-protein from HDL by rat adrenocortical cells with 
time. Primary confluent monolayer cultures of rat adrenocortical 
cells, pretreated for 48 h with ACTH M) in LPP media, were 
incubated for the indicated times with ACTH M), AG (0.8 mM), 
and 3H-CE-'251-HDL. The cells were thoroughly washed and extracted 
with isopropyl alcohol. The cell-associated lZ5I remaining in the cell 
extract and the extracted total [3H]cholesterol were counted. The 
mean and S.D. of triplicate  determinations from a single experiment 
representative of three similar experiments are shown. 
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FIG. 10. Concentration-dependence of fluorescent steroid 
production, 3H-steroid production, and cell 'H-sterol accu- 
cortical cells, pretreated for 48 h with ACTH (10" M) in LPP media, 
mulation. A,  primary confluent monolayer cultures of rat adreno- 
were incubated for 18 h with ACTH ( M) and increasing concen- 
trations of 3H-CE-HDL. Separate multiwell plates (24 X 15 mm) 
were used to measure total fluorogenic steroids (0) and 3H-steroid 
(A) production in the absence of AG or 3H-sterol (0) accumulation 
in the presence of  AG (0.8 mM). Total fluorogenic steroid production 
was estimated from measurements of corticosterone equivalents as 
described in the text. Micrograms of 3H-sterol accumulation and 3H- 
steroid production have been calculated from total dpm divided by 
the specific activity of cholesteryl ester in added HDL. B, Each 
response curve in A was individually normalized by dividing all values 
in each curve by the maximum value for that parameter. The maxi- 
mum value for each parameter occurred at the maximum HDL 
concentration tested. Inset: double reciprocal plot of the normalized 
values for all parameters. 
linear increase over the ensuing 24 h (Fig. 8). The terminal 
rate of uptake of cholesteryl ester was 43 ng/well/h. To 
determine the extent to which cell-bound lipoprotein ac- 
counted for uptake of 3H-CE, we compared cell accumulated 
cholesteryl ester with cell-metabolized lZ5-I-apoHDL (Fig. 9). 
The total amount of lZ5I-apoHDL metabolized by the cells 
theoretically includes both cell-associated material and deg- 
radation products. The  latter were assessed as non-trichloro- 
acetic acid precipitable lZ5I in the media. When compared 
with cell-free controls, however, we could detect no difference 
in  the amount of non-trichloroacetic acid precipitable lZ5I in 
media from cells incubated with '"I-HDL when compared 
with media from cell-free incubations. Thus,  the  data shown 
in Fig. 9  report only cell-associated lz5I. Moreover, the amount 
of cholesterol associated with degraded apoproteins was less 
than 10% of total metabolized cholesteryl ester. The rate of 
increase in cell-associated 3H-sterols was much greater than 
the rate of increase in cell-associated lZ5I. Moreover, the 
amount of cholesteryl ester  taken up by the cells, based on 
measurements of accumulated 3H-sterols, greatly exceeded 
the amount of cholesterol associated with the bound HDL 
estimated from measurements of cell-accumulated lZ5I. The 
ratio of cell-associated 3H-sterols to cell-associated lZ5I- 
apoHDL increased with the duration of incubation. The ratio 
of cell-associated 3H-sterols to cell-associated '251-HDL, when 
compared with the 3H-'251 ratio  in unincubated HDL, was 5- 
fold greater at 1 h and more than 35-fold greater at 24 h 
indicating selective metabolism of cholesteryl esters compared 
with apoHDL. 
The effects of increasing HDL  concentration on (i) fluores- 
cent steroid production, (ii) production of 3H-labeled steroid 
products, and (iii) cell-associated [3H]cholesterol and choles- 
teryl esters was determined by incubating 3H-CE-1.125B at 
increasing concentrations with ACTH/LPP-pretreated cells. 
Cell-associated counts were determined in the presence of 
AG, to prevent conversion to corticosterone while AG was 
omitted for measurements of fluorescent and 3H-steroids. All 
three  parameters exhibited similar dependence on HDL con- 
centration (Fig. 1OA). To more directly compare the dose 
response curves for the  three outcome parameters, each curve 
was normalized by dividing all values by the maximum ob- 
served value  which in each case occurred at  an HDL concen- 
tration of 100 pg of cholesterol/ml. The normalized dose 
response curves were virtually coincident (Fig. 1OB). The 
response curves were  complex, increasing steeply at low HDL 
concentrations  but much more gradually at higher HDL con- 
centrations. When the combined normalized response curves 
were analyzed graphically, a nonlinear double reciprocal plot 
was observed (inset Fig. 10B). The double reciprocal plot 
could be resolved into two linear components. The concentra- 
tions of HDL required to half-maximally stimulate the two 
processes suggested by this method of analysis were  16.3 and 
54.9  pg  of HDL cholesterol/ml. The  latter is consistent with 
our earlier studies  (5) which suggests that half-maximal HDL 
concentration for enhanced fluorogenic steroid production 
and cell cholesterol accumulation is at least 70 pg of HDL 
cholesterol/ml. 
DISCUSSION 
Previous studies of adrenal HDL metabolism, by us (5, 15, 
40) and  others (6-8, 41-51) demonstrate that HDL delivers 
steroidogenic substrate cholesterol and replenishes cellular 
cholesterol stores by a non-endocytotic process. We have 
recently presented evidence that both unesterified cholesterol 
and cholesteryl esters from HDL can be utilized for steroido- 
genic substrate (14). Additional support for a role of choles- 
teryl esters arises from the studies of Glass et al. (5, 6) and 
Stein et al. (7, 8) showing that  the  rat adrenal cortex selec- 
tively accumulates cholesteryl ester,  a cell-retained nonhydro- 
lyzable cholesteryl ester analog, from HDL. This elegant 
approach, most useful for quantitating tissue cholesteryl ester 
uptake in  vivo, does not permit investigation of subsequent 
Adrenal Metabolism of HDL Cholesteryl Ester 8147 
intracellular cholesteryl ester metabolism. In  addition,  ether 
analogs could interfere with or modify normal ester metabo- 
lism (52). Fortunately, in a closed in uitro system, trapped 
analogs are  not essential for studying ester metabolism since 
both  intra-  and extracellular cholesteryl ester metabolites can 
be quantitatively recovered. Thus,  the  current studies, which 
were undertaken to directly characterize rat adrenal metabo- 
lism of cholesteryl esters, have employed HDL labeled exclu- 
sively in  the cholesteryl ester moiety. 
To ensure that results we obtained employing radiolabeled 
cholesteryl esters accurately reported the activity of native 
HDL cholesteryl esters, we sought to demonstrate that  the 
labeling procedure did not  alter  HDL activity and that  the 
labeled and unlabeled cholesteryl esters behaved identically. 
Comparing enhancement of ACTH-stimulated steroid pro- 
duction by labeled and unlabeled HDL provides an unique 
opportunity to evaluate the effects of labeling on HDL  func- 
tion since HDL-enhanced steroidogenesis is one of only a few 
established physiologic functions of HDL. Two observations 
indicate that  the labeling procedure did not  alter  HDL  struc- 
ture.  First, labeled and unlabeled HDL, when added to cul- 
tured cells at equivalent cholesterol concentrations, produce 
identical increases in ACTH-stimulated steroidogenesis. Sec- 
ondly, the dose response curves for enhanced fluorogenic 
steroid production and production of 3H-steroids exhibited an 
identical dependence on HDL  concentration. The latter ob- 
servation further  indicates that incorporated [3H]cholesteryl 
esters behave the same as endogenous cholesteryl esters. Since 
we wished to examine apoE and apoB,E receptor-independent 
cholesteryl ester  uptake we chose to use human HDL3,  which 
is free of apoB, apoE,  and  other  apoproteins recognized by 
endocytosed receptors. To ensure that HDL-associated apoE 
was not responsible for cholesteryl ester  uptake we often used 
HDL  preparations freed of apoE by heparin-Sepharose chro- 
matography. We could detect no significant differences in  the 
metabolism of 3H-CE-1.125B, 3H-CE-HDL, or 3H-CE-apoE- 
free HDL. The labeling procedure and lipoprotein prepara- 
tions used in this study thus provided a suitable and conven- 
ient  means of obtaining labeled HDL which (i)  retains normal 
function, (ii) is labeled solely in the cholesteryl ester moiety, 
and  (iii)  are  not endocytosed. 
Since the current studies were designed to obviate the 
contribution of apoB,E receptor-mediated endocytosis to total 
HDL-CE metabolism we elected to use human HDL since rat 
HDL  cannot be entirely freed of apoE. Dyer and Curtiss (53) 
have recently reported that addition of human rat apoE-rich 
HDL to cultured rat ovarian cells selectively stimulates pro- 
gesterone production while apoE-free HDL stimulated  both 
progesterone and androgen production. These investigators 
have proposed that apoE  inhibits luteinizing hormone stim- 
ulated increases in 17-hydroxylase, 17-20  lyase  enzyme activ- 
ity. In earlier  studies ( 5 ) ,  we could detect no differences in 
total fluorogenic steroid production by cells incubated with 
human or rat HDL added at equal cholesterol concentrations 
nor could we detect, by TLC, differences in the types of 
steroids produced in the presence and absence of human HDL. 
The possibility remains that  rat HDL which contains apoE 
or human HDL containing apoE may alter the types of 
adrenal steroids produced when compared with apoE-free 
HDL. Studies  are  currently underway to answer this  intrigu- 
ing question. 
The studies reported here directly demonstrate that choles- 
teryl esters from HDL can be taken  up  and used as  substrate 
for steroid hormone production. The 3H products extracted 
from the media and isolated by TLC were not produced in 
the absence of cells and were prevented from accumulating 
by  AG an inhibitor of cytochrome P-450 side chain cleavage, 
the committed step  in steroid hormone synthesis. Similarly, 
inhibition of energy metabolism by cyanide/fluoride blocked 
both fluorogenic sterol  and  3H-sterol production. Moreover, 
the labeled products extracted from the media with methylene 
chloride migrated coincident with or adjacent to unlabeled 
corticosterone and  other steroid products in our TLC systems. 
The major steroid products secreted by cultured rat adre- 
nocortical cells include corticosterone, 18-hydroxycorticoster- 
one, and deoxycorticosterone (54). We have previously re- 
ported ( 5 )  that these steroid products migrate to  three poorly 
separate positions in  the  TLC system used.  We have combined 
these  spots in counting 3H-steroid products. Together  they 
comprise the total cholesteryl ester undergoing side chain 
cleavage. Thus,  the steroid products we have isolated provide 
a quantitative estimate of the amount of HDL cholesteryl 
esters converted to steroidogenic products. The amount of 
steroidogenic substrate derived from HDL cholesteryl esters 
is equivalent to  the number of counts recovered as steroid 
products divided by the specific activity of added cholesteryl 
esters. When the amount of cholesteryl ester in HDL was not 
directly measured, we have assumed that  it constituted 85% 
of the total HDL cholesterol (55, 56). To determine the 
percent of steroid product derived from HDL cholesteryl ester, 
it was also necessary to estimate the  total quantity of steroid 
hormone produced. Fluorescent measurements do not directly 
measure total steroid production since not  all steroid products 
yield an equivalent molar fluorescent signal. However, total 
steroid production can be estimated if the relative abundance 
of the products and  their individual fluorescent intensities 
relative to the corticosterone standard are known. Of the 
major steroid products, only corticosterone fluoresces signifi- 
cantly (54). O’Hare and Neville (54), using radiolabeled preg- 
nenolone, have shown that corticosterone constitutes approx- 
imately 50% of the total steroid production of cultured rat 
adrenal cells. Thus, fluorescence measurement, using corti- 
costerone as  a  standard,  underestimates  total steroid mass by 
about 50%. The calculated contribution of cholesteryl esters 
to total steroid synthesis, based on these assumptions, varied 
from 24.5 to 100% and averaged 50 & 18% (Table I) .  Thus, 
under the conditions of these experiments, the ester  portion 
of HDL accounts for the majority of extracellular substrate. 
In  the experiments reported in  Table I, total steroid output 
ranged from 0.42 to 2.6 pg/well/l8 h. The average protein 
content/well was 66.6 * 9.5 pg (triplicate measures from  four 
preparations). Assuming the adrenal cortex is approximately 
10% protein by weight, steroid production at  an HDL concen- 
tration of 100 pg of cholesterol/ml, in our system would be 
approximately equivalent to 217  pg/g tissue/h. The reported 
circulating concentration of HDL cholesterol in the rat is 
approximately 300 pg/ml (57, 58). Thus, at circulating HDL 
concentrations, in vitro steroid production can be estimated 
to be 600-700 pg/g tissue/h. The initial  rate of steroid pro- 
duction by prestimulated cells is perhaps twice as great as  the 
rate at later times. However, this is considerably less than  the 
maximal in vivo rate  estimated by Spady and Dietschy (59) 
to be 4300 Fg/g/h. The reasons for this difference are not 
known but could reflect the inherent uncertainties in the 
various estimates employed, differences in the degree of stim- 
ulation or responsiveness of tissues i n  uiuo and i n  uitro and/ 
or the amount of available cholesterol substrate. I n  uiuo free 
cholesterol in HDL consumed by adrenal steroidogenesis can 
be constantly replenished at other  sites in the circulation. I n  
vitro the continuous replacement of consumed free cholesterol 
cannot occur. Thus, the contribution of free cholesterol is 
more limited i n  uitro than i n  uiuo. 
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Over the course of an 18 h in uitru incubation using ACTH/ 
LPP-pretreated cells, our results indicate that 70-100% of 
substrate is derived from HDL cholesteryl esters. These find- 
ings are  consistent with and supportive of the in vivo obser- 
vation of Spady and Dietschy (59) showing that endogenous 
cholesterol synthesis provides only 2 4 %  of substrate.  Inter- 
estingly, the percentage of steroid products derived from 
cholesteryl esters consistently decreased as  the concentration 
of HDL increased. Two explanations might explain this  find- 
ing. First, increasing HDL concentration might stimulate 
endogeneous cholesterol synthesis (60). Alternatively, and we 
believe more likely based on our earlier inability to detect 
changes in cholesterol synthesis  (5), unesterified cholesterol 
in HDL could provide an increasing percentage of substrate 
at higher HDL  concentrations. In either event, at circulating 
concentrations, cholesteryl esters appear to provide the ma- 
jority of substrate cholesterol in vitro. 
The current studies shed light on the mechanism and 
regulation of HDL cholesterol uptake. At least three mecha- 
nisms could explain adrenal  uptake of cholesteryl ester from 
HDL. First cholesteryl esters could be hydrolyzed and the 
resultant unesterified cholesterol taken up by a process of 
aqueous diffusion (3, 13). Our results indicate this is not  the 
case. In the absence of cells, the rate of cholesteryl ester 
hydrolysis is much too slow to account for the observed uptake 
of [3H]cholesteryl ester. Moreover, a  substantial proportion 
of the accumulated [3H]cholesterol was recovered in  the  ester 
form. If accumulation of HDL cholesteryl ester were mediated 
by hydrolysis and reesterification, then Sandoz 58-035, an 
inhibitor of acyl  coenzyme Acholesterol acyltransferase, 
should have decreased cell [3H]cholesteryl ester accumulation. 
It did not. 
At  least two observations indicate that  the cellular accu- 
mulation of cholesteryl ester  cannot be attributed  to lipopro- 
teins bound to the cell surface. First, we have previously 
shown that the majority of surface-bound HDL is rapidly 
released by repeated washing or by decreasing the extracel- 
lular concentration (30). Second, the amount of surface-bound 
HDL was directly estimated by measurement of cell-bound 
iodinated apoprotein. The ratio of cell accumulated 3H-CE to 
bound "51-apoprotein increased progressively and dramati- 
cally with time. Thus,  the accumulation of 3H-CE occurs in 
excess of bound lipoprotein. 
Interestingly, in contrast  to studies reported by Veldhuis et 
al. (61) in swine granulosa cells, inhibition of cholesterol 
esterification by Sandoz 58-035 did not enhance steroid hor- 
mone production. This difference in response could be due 
either to cellular differences in rates of unesterified choles- 
terol production from cholesteryl ester  stores or to differences 
in the rate of free cholesterol transport  or utilization. In  any 
event, it appears that inhibition of esterification does not 
uniformly drive steroid hormone production in all species and 
steroidogenic glands. Finally, the inability of Sandoz 58-035 
to alter rates of 3H-steroid production from 3H-CE HDL, 
indicates that accumulated HDL cholesteryl ester need not 
move through intracellular cholesteryl ester storage pools 
before undergoing side chain cleavage. The factors which 
influence the distribution of accumulated cholesteryl esters 
between storage and steroidogenic substrate pools are  not yet 
known. 
A second mechanism which could cause HDL cholesteryl 
ester uptake is receptor-mediated endocytosis (2). Three ob- 
servations indicate that  this is not the mechanism of uptake. 
First, the lipoproteins used in these studies were free of 
apoproteins which bind to currently recognized receptors. 
Second, the rate of HDL degradation, estimated by production 
of nontrichloroacetic acid precipitable iodinated apoprotein 
products, was insufficient to account for the amount of cho- 
lesteryl ester accumulated. Third, although specific HDL deg- 
radation was nearly completely inhibited by chloroquine, hy- 
drolysis of HDL cholesteryl esters was not, indicating that 
hydrolysis of HDL cholesteryl esters does not occur intraly- 
sosomally (62). The lack of lysosomal cholesterol hydrolysis 
and  the minimal amount of apoprotein degradation further 
indicates that uptake of HDL cholesteryl esters is not me- 
diated by apoE secreted by the adrenal (63, 64) which then 
binds to added apoE-free HDL (65)  and mediates uptake via 
the apoB,E receptor. 
A third mechanism for HDL cholesteryl ester  uptake, sug- 
gested by our earlier studies (5,14)  and those of Pittman  and 
his colleagues (7)  is pecific cholesteryl ester membrane trans- 
port. Several properties of the uptake process are revealed by 
our studies. First, in ACTH-stimulated cells uptake progresses 
linearly with time for up to 26 h. Immediately following 
addition of 3H-CE-HDL to cells there is an initial rapid 
increase in cell-associated 3H-sterols. The initial rapid uptake 
is similar in duration to  the initial  rate of 9 - H D L  binding 
we have  previously reported (30). However, even at  the end 
of the 40-60-min period the ratio of cell accumulated 3H- 
sterol to cell-bound lZ5I-HDL exceeds the ratio in unincubated 
HDL indicating that selective uptake begins without delay in 
cells pretreated with ACTH. Subsequently, the  rate of 3H- 
sterol accumulation continues linearly and greatly exceeds 
the rate at which cells accumulate '251-apoprotein. Second, 
uptake of HDL cholesteryl ester is mediated by a  saturable 
process as indicated by the finding that addition of excess 
unlabeled HDL inhibits  not only production of 3H-steroids 
but also uptake per se. Further support for the saturable 
nature of the uptake process is provided by the HDL dose 
response curve (Fig. 10). Examination of the dependence of 
cholesteryl ester  uptake  and conversion to steroid hormones 
on HDL concentration suggests that these processes are com- 
prised of at least two components, one of high and one of low 
affinity. It is not surprising that a complex dose response 
curve was observed since, undoubtedly, many steps occur 
between cell membrane HDL contact and cell cholesteryl 
ester accumulation and production of steroid products. We 
estimate the concentration of HDL required for half-maximal 
effect on the high affinity process to be approximately 16-20 
pg of HDL cholesterol/ml. The  current studies, which  were 
conducted at relatively low HDL  concentrations,  permit only 
a rough estimate of the concentration of HDL required to 
half-maximally stimulate the low affinity process. By double 
reciprocal analysis, that concentration was estimated to be 
approximately 55 pg  of HDL cholesterol/ml. This is consist- 
ent with our earlier studies showing that half-maximal HDL 
stimulation of steroid production and cholesterol accumula- 
tion occur at 230 and 210 pg of HDL-protein/ml.  In the  rat 
circulating HDL cholesterol concentration  is approximately 
300 pg/ml(57,58),  a  concentration sufficient to fully saturate 
the high affinity process but one in which regulation of steroid 
output would still be dependent on circulating levels by virtue 
of the lower affinity process. The physical process(es) respon- 
sible for these complex HDL kinetics are  not yet known but 
undoubtedly involve membrane-HDL binding as well as 
transmembrane and intracellular cholesteryl ester transfer 
and hydrolysis. 
Third,  the coincident dependent of fluorescent steroid pro- 
duction, cholesteryl ester accumulation, and production of 3H 
steroids suggests that under the conditions employed in our 
studies, the  rate of cholesteryl ester  uptake determines the 
rate of subsequent processes. Finally, HDL cholesteryl ester 
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uptake was not inhibited by inhibition of steroidogenesis. 
Aminoglutethimide which  is a competitive inhibitor of cho- 
lesterol side chain cleavage (66), effectively prevented synthe- 
sis of 3H-steroids from 3H-HDL cholesteryl esters but also 
produced a compensatory equivalent increase in cell-associ- 
ated [3H]cholesteryl esters. Interestingly, addition of  AG did 
not redirect [3H]cholesteryl esters  into  a hydrolytic pathway. 
This is consistent with earlier findings of Mahaffee et al. (67) 
who have shown that addition of AG, while inhibiting side 
chain cleavage, does not prevent mitochondrial cholesterol 
accumulation. Freeman (68) has recently suggested that AG 
impedes movement of unesterified cholesterol from the 
plasma membrane to  the mitochondrion. The apparent dis- 
parity between these two sets of observations could be ex- 
plained either by cell-specific differences or by differences in 
handling of unesterified cholesterol and cholesteryl esters. 
Cholesteryl esters  taken up by rat adrenal cells from HDL 
can be disposed of in five  ways. If hydrolyzed they  can be (i) 
converted to steroid hormones or (ii) retained within the cell 
as unesterified cholesterol or (iii) released back into  the media. 
If not hydrolyzed, they  can be (iv) retained within the cell or 
(v) released into the media. The  current studies do not allow 
us to determine the  extent of resecretion of cholesteryl esters. 
Exclusion of this  potential pathway would not affect estimates 
of net cellular uptake of HDL cholesteryl ester but would 
cause underestimation of total cell HDL cholesteryl ester 
metabolism. The current  studies  demonstrate that  rat adrenal 
cells, not surprisingly, hydrolyze HDL cholesteryl esters. Two 
observations support this contention; these include direct 
measurements of 3H-unesterified cholesterol production and 
the fact that HDL cholesteryl esters can be converted to 
steroid production since cholesteryl esters must first be hy- 
drolyzed to undergo side chain cleavage. Two observations 
indicate that HDL cholesteryl ester hydrolysis is not lysoso- 
mally mediated. First, although cholesteryl ester metabolism 
increased linearly with time up to 24 h  after the initial more 
rapid increase, there is no concomitant degradation to non- 
trichloroacetic acid susceptible products of the associated 
apoproteins indicating that  the particle was not endocytosed 
intact. Second, the hydrolysis of HDL cholesteryl esters is 
not inhibited by chloroquine which is known to inhibit lyso- 
somal function. Rat adrenal cells possess at least two choles- 
teryl ester hydrolases (69), an acid optimal and  neutral 
ACTH-regulated enzyme. The failure of chloroquine to inhibit 
HDL cholesteryl ester hydrolysis indicates that  the lysosomal 
enzyme is not responsible for the observed hydrolysis. 
Our findings suggest that  the  rate of cholesteryl ester up- 
take exceeds the rate of hydrolysis since both 3H-unesterified 
cholesterol and [3H]cholesteryl esters accumulate with time 
when cells are presented with HDL [3H]cholesteryl ester. The 
apparent difference in the  rate of uptake  and hydrolysis could 
be  due to inherent properties of the responsible cholesteryl 
esterase or to compartmentalization. Perhaps, cholesteryl es- 
ters  entering by high and low affinity uptake  enter different 
pools,  only one of which is subject to immediate hydrolysis. 
These findings may explain our  earlier observation that ad- 
dition of HDL produces not only increased steroid hormone 
production but also a concomitant increase in cell cholesterol 
content. 
Interestingly, however, cell-associated iodinated apoprotein 
also accumulates steadily throughout this period (30). The 
relationship of apoprotein accumulation to cholesterol uptake 
and metabolism is unknown. The utilization of cholesteryl 
esters in HDL consumed a considerable portion of added 
cholesteryl esters (up to 17% of added counts, at low HDL 
tive uptake of HDL cholesteryl ester is not confined to  an 
unique HDL subfraction. The removal of such a large per- 
centage of cholesteryl ester from HDL would be expected to 
result in formation of redundant surface constituents.  Per- 
haps this is the force which leads to slow but persistent cell 
accumulation of apoA-I in uitro observed in the  current  stud- 
ies and previously reported (30). Such cell-mediated altera- 
tions in HDL structure could alter subsequent HDL  function 
and catabolism, perhaps serving as  a signal for HDL removal 
from the circulation. 
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